Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
TENOFOVIR DISOPROXIL FUMARATE
香港商吉立亞醫藥有限公司台灣分公司 臺北市信義區松仁路32號10樓之1、36號10樓之1 (54376860)
J05AF07
膜衣錠
TENOFOVIR DISOPROXIL FUMARATE (0818003510) Equivalent to tenofovir disoproxil 245mg
塑膠瓶裝
製 劑
須由醫師處方使用
GILEAD SCIENCES INC. 333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA(CA) 94404, USA US
tenofovir disoproxil
1.Viread適用於與其他抗反轉錄病毒藥物合併使用於成人HIV-1感染之治療。2.Viread適用於與其他抗反轉錄病毒藥物併用,治療對NRTI產生抗藥性,或因毒性反應無法使用第一線藥物治療之HIV-1感染的12歲(含)至18歲小兒患者。3.Viread用於治療具有病毒複製及活動性肝臟發炎証據之慢性B型肝炎的成人與12歲及以上小兒患者。
有效日期: 2027/08/31; 英文品名: Viread Tablets
2007-08-31
5% 5% d 18% 12% a. b. c. d. Stavudine 40% 9% VIREAD 19% 1% VIREAD Stavudine 3 3 4 3 903 VIREAD ≥ 1% 3-4 0 144 VIREAD+3TC+EFV d4T+3TC+EFV N=299 N=301 ≥ 3 36% 42% > 240 mg/dL 19% 40% > 990 U/L ; > 845 U/L 12% 12% > 175 U/L 9% 8% AST > 180 U/L ; > 170 U/L 5% 7% ALT > 215 U/L ; > 170 U/L 4% 5% > 100 RBC/HPF 7% 7% < 750/mm 3 3% 1% > 750 mg/dL 1% 9% 934 934 511 VIREAD+EMTRIVA ® efavirenz N=257 zidovudine/lamivudine efavirenz N=254 4 903 HIV-1 144 VIREAD+ lamivudine+efavirenz BMD -2.2% 3.9 stavudine+lamivudine+efavirenz -1.0% 4.6 BMD VIREAD -2.8% 3.5 stavudine -2.4% 4.5 BMD 24- 48 144 28% VIREAD 21% stavudine BMD 5% BMD 7% 4 VIREAD 6 stavudine stavudine VIREAD 酶 肽 肽 1,25 D ; 酶 5.6 4 934 5% a 2 4 ≥ 0 144 VIREAD b +FTC+EFV AZT/3TC+EFV N=257 N=254 9% 5% 9% 7% 2% 5% 9% 8% 8% 4% 8% 5% 5% 3% 6% 5% 8% 7% 9% 7% 5% 7% c 7% 9% a. b. 96 144 TRUVADA efavirenz VIREAD+ EMTRIVA efavirenz c. 5 5 934 ≥ 1% 0 144 VIREAD a +FTC+EFV AZT/3TC+EFV N=257 N=254 ≥ 3 30% 26% > 240 mg/dL 22% 24% > 990 U/L > 845 U/L 9% 7% > 175 U/L 8% 4% > 550 U/L 1% 0% AST > 180 U/L > 170 U/L 3% 3% ALT > 215 U/L > 170 U/L 2% 3% < 8.0 mg/dL 0% 4% > 250 mg/dL 2% 1% > 75 RBC/HPF 3% 2% ≥ 3+ < 1% 1% < 750/mm 3 3% 5% > 750 mg/dL 4% 2% a. 96 144 TRUVADA efavirenz VIREAD+ EMTRIVA efavirenz 1% 907 6 907 48 6 907 ≥ 3% a 2 4 0 48 VIREAD N=368 0-24 N=182 0-24 VIREAD N=368 0-48 VIREAD N=170 24-48 7% 6% 11% 1% 7% 7% 12% 4% 5% 5% 8% 2% 4% 3% 7% 6% 3% 3% 4% 2% 3% 1% 3% 2% 2% 2% 4% 2% 11% 10% 16% 11% 8% 5% 11% 7% 4% 1% 7% 5% 3% 2% 4% 1% 3% 2% 4% 2% 3% 1% 4% 1% 2% 0% 3% 2% 4% 3% 8% 4% 3% 2% 4% 4% b 3% 3% 5% 2% 1% 3% 3% 1% c 5% 4% 7% 1% 3% 2% 3% 1% 3% 3 % 4% 1% 2% 1% 4% 2% a. b. c. VIREAD 7 3 4 7 907 VIREAD ≥ 1% 3-4 0 48 VIREAD N=368 0-24 N=182 0-24 VIREAD N=368 0-48 VIREAD N=170 24-48 ≥ 3 25% 38% 35% 34% > 750 mg/dL 8% 13% 11% 9% > 990U/L > 845 U/L 7% 14% 12% 12% > 175 U/L 6% 7% 7% 6% ≥ 3+ 3% 3% 3% 2% AST > 180 U/L > 170 U/L 3% 3% 4% 5% ALT > 215 U/L > 170 U/L 2% 2% 4% 5% > 250 U/L 2% 4% 3% 3% < 750/mm 3 1% 1% 2% 1% HIV-1 12 12 87 48 VIREAD N=45 Read the complete document